The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medical centers.
More than a dozen patient groups representing millions of Americans with serious and chronic health conditions are praising the Biden administration’s action to preserve protections in the Affordable Care Act (ACA) for lesbian, gay, bisexual, transgender and queer (LGBTQ) patients receiving health care services.
A new report from the American Cancer Society Cancer Action Network (ACS CAN) takes an in-depth look at disparities across all areas of cancer research and suggests immediate policy solutions that could help address such gaps in the years to come.
A group of more than fifty cancer research-focused organizations are urging Congress to include $10 billion in emergency funding to restart cancer research and clinical trials at the National Institutes of Health (NIH) stalled by the coronavirus pandemic.
The American Cancer Society Cancer Action Network (ACS CAN) is urging President Biden and Congress to work together to prioritize access to affordable health care in any forthcoming infrastructure legislation
ACS CAN President Lisa Lacasse reacts to President Biden's declaration we will, "End cancer as we know it." The statement was part of the president's address to a joint session of Congress.
Karen E. Knudsen, MBA, Ph.D., will be the next chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), starting June 1, 2021. She will take the reins from the retiring Gary Reedy, who has served as both organizations’ CEO since 2015.
Today the Biden administration released preliminary details on its FY 2022 discretionary budget, including $6.5 billion to create a new department within the National Institutes of Health (NIH) dedicated to accelerating the pace of biomedical research for rare and difficult to treat diseases.
The American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) are committed to reducing cancer incidence and deaths nationwide.
The Centers for Medicare and Medicaid Services (CMS) announced this week that it will not proceed with additional flexibilities to a Part D Payment Modernization Model that would have allowed participating Medicare Part D plans to limit coverage of drugs within the “six protected drug classes.”